Home 
Bratislava Medical Journal 2015 Bratislava Medical Journal Vol.116, No.9, p.533–538, 2015
Bratislava Medical Journal 2015 Bratislava Medical Journal Vol.116, No.9, p.533–538, 2015
Journal info
|
||||
Select Journal
Journals
Bratislava Medical Journal 2024 Ahead of print 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 Endocrine Regulations General Physiology and Biophysics Neoplasma Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
Bratislava Medical Journal Vol.116, No.9, p.533–538, 2015 |
||
| Title: The use of antiplatelet medication in hospitalised elderly patients | ||
| Author: M. Wawruch, V. Slezakova, J. Murin, M. Kuzelova, A. Dukat, M. Zabka, T. Leitmann, J. Tisonova, Z. Kallay | ||
| Abstract: BACKGROUND: The use of antiplatelet agents is strongly recommended for the secondary prevention of ischemic events such as myocardial infarction, stroke/transient ischemic attack (TIA). OBJECTIVES: The aim of our study was to analyse the use of antiplatelet medication in patients after myocardial infarction, stroke/TIA, and patients with both conditions and to identify patient-related characteristics, which determine the use of such drugs in elderly patients. METHODS: Study sample (n = 372) was derived from 2,157 patients admitted to long-term care departments of three municipal hospitals. The study included patients aged ≥65 years after myocardial infarction, stroke/TIA or both. RESULTS: Antiplatelet medications were prescribed in 54.8 % and 68.5 % of patients at hospital admission and discharge, respectively. Hospitalisation led to a significant increase in the use of antiplatelet medication in patients after myocardial infarction and in those with the combination of both events. However, in patients after only stroke/TIA, we did not find any significant difference comparing the use of antiplatelet medication at the time of hospital admission and discharge, respectively. CONCLUSION: Our study revealed that physicians are more aware of the benefits of antiplatelet medication in elderly patients after myocardial infarction or those after both myocardial infarction and stroke/TIA in comparison with patients after only stroke/TIA (Tab. 3, Ref. 32). |
||
| Keywords: myocardial infarction, cerebrovascular, stroke, transient ischemic attack, bleeding risk, thrombotic event. | ||
| Published online: 24-Sep-2015 | ||
| Year: 2015, Volume: 116, Issue: 9 | Page From: 533, Page To: 538 | |
| doi:10.4149/BLL_2015_102 |
||
|
|
 download file |
|